FDA Approves Sarclisa (isatuximab) for Multiple Myeloma in Three Combinations
FDA approves Sarclisa for multiple myeloma in three drug combinations.
The FDA approved Sarclisa (isatuximab) for adult patients with multiple myeloma in three combination regimens: with pomalidomide and dexamet…
The FDA approved Sarclisa (isatuximab) for multiple myeloma. It is used in three different combinations for patients at various stages of th…
FDA Approves Trelstar (triptorelin) for Advanced Prostate Cancer
FDA approves Trelstar for advanced prostate cancer treatment.
FDA approved Trelstar (triptorelin) for advanced prostate cancer. It is a GnRH agonist administered as intramuscular injection. Dosing sched…
The FDA approved Trelstar (triptorelin) to treat advanced prostate cancer. It lowers testosterone to slow cancer growth. This gives patients…
FDA Approves Trelstar (triptorelin pamoate) for Advanced Prostate Cancer
FDA approves new drug Trelstar for advanced prostate cancer.
The FDA approved Trelstar (triptorelin pamoate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered as a single…
The FDA approved Trelstar (triptorelin pamoate) to treat advanced prostate cancer. It lowers testosterone levels to slow cancer growth. This…
FDA Approves Trelstar (triptorelin pamoate) for Advanced Prostate Cancer
FDA approves Trelstar for advanced prostate cancer treatment.
The FDA approved Trelstar (triptorelin pamoate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered as a single…
The FDA approved Trelstar (triptorelin pamoate) for advanced prostate cancer. It lowers testosterone to slow cancer growth. This gives patie…
Catheterisation Linked to Small PSA Rise in Men
Urinary Catheters May Cause Small Increases in Prostate PSA Levels
A meta-analysis of 9 studies found that indwelling urethral catheterisation causes a small but statistically significant increase in serum P…
Short-term urinary catheters can cause small increases in prostate PSA levels, but these changes may not affect clinical decisions for short…
Multidisciplinary management of mixed adenoneuroendocrine carcinoma of the gallbladder involves surgery and adjuvant chemotherapy
Rare gallbladder cancer type shows specific genetic markers and traits
This case report and literature review describes the clinical management of a patient with mixed adenoneuroendocrine carcinoma of the gallbl…
A rare form of gallbladder cancer, known as GB-MANEC, was identified in a patient who underwent surgery and chemotherapy with no recurrence …
Multimodal strategies including bevacizumab and advanced radiotherapy techniques manage radiation-induced brain necrosis
New strategies help manage radiation-induced brain tissue damage
This narrative review synthesizes the pathogenesis, prevention, and treatment of radiation-induced brain necrosis (RBN) in patients with int…
Doctors are identifying new ways to prevent and treat brain tissue death caused by radiation during head and neck cancer treatments.
FDA Approves Orserdu (elacestrant) for ESR1-Mutated Advanced Breast Cancer
FDA approves new pill for advanced breast cancer with ESR1 mutation.
FDA approved Orserdu (elacestrant) for postmenopausal women and men with ER+/HER2- advanced or metastatic breast cancer with ESR1 mutations …
The FDA approved Orserdu (elacestrant) for certain advanced breast cancers with an ESR1 mutation. It is for patients whose disease has worse…
Pretreatment CPS and HPV status correlate with pathological response in neoadjuvant immunotherapy for LAHNSCC
Certain markers may predict how well immunotherapy treats head cancer
This meta-analysis of 26 studies involving 980 patients with locally advanced head and neck squamous cell carcinoma (LAHNSCC) found that hig…
New data suggests that specific biological markers can help doctors predict how well a patient's tumor will respond to immunotherapy.
Non-pharmacological interventions may improve sleep quality, quality of life, and anxiety in lung cancer patients
Non-drug treatments may improve sleep and anxiety in lung cancer
This systematic review and meta-analysis of 2604 lung cancer patients found that non-pharmacological interventions may have a positive effec…
New data suggests that non-drug therapies can help lung cancer patients sleep better, feel less anxious, and improve their overall quality o…
Acupuncture Efficacy in Managing Cancer Related Fatigue and Quality of Life
Acupuncture may reduce fatigue in breast cancer survivors
Meta-analysis indicates acupuncture significantly reduces cancer-related fatigue and improves sleep quality for breast cancer survivors.
New research suggests acupuncture can significantly lower fatigue and improve sleep quality for people living with breast cancer.
Multiple clinical and perioperative factors are significantly associated with postoperative abdominal infection in colorectal cancer patients
Meta-analysis reveals key risk factors for infection after colorectal surgery
This meta-analysis of 21 case-control studies identifies significant differences between infection and non-infection groups across various r…
A new meta-analysis of 21 studies identifies 22 factors that raise the risk of abdominal infection after colorectal cancer surgery.